Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Patent: 10,034,938

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,034,938
Title:Method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
Abstract: The invention relates to methods of treating melanoma using a herpes simplex virus in combination with an immune checkpoint inhibitor.
Inventor(s): Vanderwalde; Ari (Memphis, TN), Shabooti; Mohamed (Agoura Hills, CA)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Application Number:14/424,424
Patent Claims:see list of patent claims

Details for Patent 10,034,938

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bristol-myers Squibb Company YERVOY ipilimumab Injection 125377 2011-03-25 ⤷  Free Forever Trial 2032-08-30
Amgen, Inc. IMLYGIC talimogene laherparepvec For Injection 125518 2015-10-27 ⤷  Free Forever Trial 2032-08-30
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 2014-12-22 ⤷  Free Forever Trial 2032-08-30
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.